Fananserin

This classification denotes a serotonin antagonist with the molecular formula C23H24FN3O2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 38QJ762ET6, chemically known as 2h-naphth(1,8-cd)isothiazole, 2-(3-(4-(4-fluorophenyl)-1-piperazinyl)propyl)-, 1,1-dioxide but generally known as fananserin, which bears US NIH Compound Identifier 60785. European Medicines Agency schedules Fananserin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07507MIG. The term FANANSERIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 8 No. 3 1994, List 34). FANANSERIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule fananserin under HS 29349990 and SITC 51579. As of Q4 2014, FANANSERIN remains the US FDA Preferred Term for this commodity. Fananserin bears US NLM identifiers UMLS ID C0526908 and NCI Concept Code C80768. SMILES: S1(=O)(=O)N(CCCN2CCN(CC2)C2CCC(F)CC2)C2C3C1CCCC3CCC2.